As shown by the results of this study, TIO3 had a synergistic effect on the inhibition of PD1 expression in immune cells and PD-L1 expression in glioma cells by interfering with the expression of TGF-β2, resulting in more potent activation of antitumor immunity. The gene discussed is CD274; the disease is glioma.